MAPT and Alzheimer disease: Okadaic acid (OKA), a potent and selective inhibitor of protein phosphatases PP2A and PP1, induces tau hyperphosphorylation and accumulation, mimicking AD-like tau pathology in both in vitro and in vivo models [8,9].